Here’s why you’re not excited enough about Pfizer’s COVID vaccine
Monday morning brought the sweet, sweet news that Pfizer’s RNA-based COVID-19 vaccine has turned out to be extremely effective in its Phase 3 trial. While the news itself has been all over social media and has resulted in an instant 5% jump in the stock market, much of the press coverage has actually been not